Related references
Note: Only part of the references are listed.Inactivation of adipose angiotensinogen reduces adipose tissue macrophages and increases metabolic activity
Monique J. LeMieux et al.
OBESITY (2016)
Plasma concentrations of extracellular matrix protein fibulin-1 are related to cardiovascular risk markers in chronic kidney disease and diabetes
Alexandra Scholze et al.
CARDIOVASCULAR DIABETOLOGY (2013)
Quantitative Analysis of the Human AKR Family Members in Cancer Cell Lines Using the mTRAQ/MRM Approach
Shenyan Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Efficacy and Safety of Traditional Chinese Medicine for Diabetes: A Double-Blind, Randomised, Controlled Trial
Linong Ji et al.
PLOS ONE (2013)
Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody
Mitsuaki Yanagida et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Overproduction of Angiotensinogen from Adipose Tissue Induces Adipose Inflammation, Glucose Intolerance, and Insulin Resistance
Nishan S. Kalupahana et al.
OBESITY (2012)
The renin-angiotensin system: a link between obesity, inflammation and insulin resistance
N. S. Kalupahana et al.
OBESITY REVIEWS (2012)
Fibulin-1 Is a Marker for Arterial Extracellular Matrix Alterations in Type 2 Diabetes
Claudia Cangemi et al.
CLINICAL CHEMISTRY (2011)
Angiotensin II exerts glucose-dependent effects on Kv currents in mouse pancreatic β-cells via angiotensin II type 2 receptors
Kwan Yi Chu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2010)
VKORC1 Pharmacogenetics and Pharmacoproteomics in Patients on Warfarin Anticoagulant Therapy: Transthyretin Precursor as a Potential Biomarker
Ramasamy Saminathan et al.
PLOS ONE (2010)
Association of the novel cardiovascular risk factors paraoxonase 1 and cystatin C in type 2 diabetes
Philip W. Connelly et al.
JOURNAL OF LIPID RESEARCH (2009)
Review of selected Chinese herbal medicines in the treatment of type 2 diabetes
Emily Wang et al.
DIABETES EDUCATOR (2008)
Impaired activity of serum alpha-1-antitrypsin in diabetes mellitus
Mohammad Hashemi et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Association between PON 1 polymorphisms, PON activity and diabetes complications
Sabine E. Hofer et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2006)
Is hypoglycaemia a marker for increased long-term mortality risk in patients with coronary artery disease? An 8-year follow-up
EZ Fisman et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2004)
Development of diabetes is retarded by ACE inhibition in hypertensive patients - a subanalysis of the Captopril Prevention Project (CAPPP)
A Niklason et al.
JOURNAL OF HYPERTENSION (2004)
Ramipril and the development of diabetes
S Yusuf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Review: Drug therapy in Chinese traditional medicine
JT Cheng
JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
